This section will contain updates from the pain industry.

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

 BioElectronics Corporation, the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management , titled " A Prospective Six-Month S...
Continue reading

FDA Approves New Treatment for Patients with Migraine

The U.S. Food and Drug Administration approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow i...
Continue reading
Topics:

AI-Powered Motion Tracking Technology for Back Pain and COPD: Interview with Rutger Flohil, US CEO of Kaia Health

Kaia Health, a health technology company based in New York City, has developed a smartphone app that can guide users through exercises to help with back pain and COPD. The technology uses AI powered motion tracking techn...
Continue reading

ATI Physical Therapy Launches ATIFirst Program and Outcomes and Best Practices Initiative

Physical therapy first offers faster diagnosis and treatment, lower health care costs and no drugs needed. Industry is beginning to shift its view of the value of using physical therapy first for chronic musculoskeletal pain conditions. 

Continue reading

FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life for People Living with Chronic Pain

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Proclaim XR™ recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform o...
Continue reading

eMindful Introduces Mindfulness Program for Chronic Pain

  eMindful , a leading provider of purpose-driven mindfulness solutions that improve health and productivity and lower healthcare costs, today announced the launch of its program for people with chronic pain. The pr...
Continue reading
Topics:

Innovative Technique Uses Neuro-Response Testing to Resolve Chronic Pain

In Boulder, Colorado, athletes and older adults suffering from chronic pain have been praising a new healing modality called the "Square 1 System." Nile Bratcher, movement coach and rehabilitation professional who specia...
Continue reading

Could a Blood Test Measure Your Pain and Mood? One Startup Believes It Can

A medical startup called MindX Sciences are working to develop a blood test using biomarker technology for those conditions that have previously been so hard to measure, including pain.   Full story.
Topics:

FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

Erchonia Corporation announces another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category in January 2002. That year, the FDA issued its first 510(k) market clearance for any low-level laser based on Erchonia's clinical trial for chronic neck and shoulder pain.

Continue reading
Topics:

First Utahns Treated in Nationwide FDA-Allowed Clinical Study of Locally Developed Cell Therapy for Chronic Low Back Pain

A clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first Utahns have been treated in its nationwide clinical study of IDCT, a locally developed injectable disc cell therapy for degenerative disc disease (DDD).

Continue reading
Topics:

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More